When Is Dupixent Considered for Eczema?
- 1 day ago
- 5 min read
You may have heard the name Dupixent mentioned perhaps by someone who has eczema, during a medical appointment, or while researching treatment options online. It may be discussed in some conversations about eczema management, particularly in selected cases where other treatments have not provided adequate control, particularly for people whose skin has not responded well to creams or other conventional treatments.
If you are wondering what Dupixent actually is, how it works, and when it might come into the picture as part of eczema care, these are reasonable questions to discuss with a dermatologist.
Many people reach a point in managing their eczema where they want to understand what else might be available, not to make a decision immediately, but to feel more informed going into conversations with their doctor. That is a thoughtful and entirely reasonable approach.
At the Medical & Surgical Dermatology Clinic, individuals come forward with concerns about eczema and undergo assessment as part of a comprehensive dermatology evaluation. Located at Novena Medical Center, the clinic supports patients across Singapore with a wide range of chronic and inflammatory skin conditions.
What Is Dupixent?
Dupixent is the brand name for a medicine called dupilumab. It is a biologic treatment, a type of therapy developed from biological sources that targets a specific part of the immune system rather than suppressing immunity broadly.
Dupilumab works by blocking the receptors for two immune signalling proteins: interleukin-4 (IL-4) and interleukin-13 (IL-13). These proteins play a central role in the type of immune response that drives atopic dermatitis (the medical term for eczema). By acting on these pathways, dupilumab is designed to reduce selected inflammatory signals involved in atopic dermatitis.
Dupixent is administered as an injection under the skin and is not a topical treatment. It was developed specifically for moderate-to-severe atopic dermatitis and has since become one of the more widely studied and used biologics in this area.
How Dupixent Works in the Context of Eczema
To understand how Dupixent works, it helps to think about what is happening in the skin during an eczema flare. The immune system, specifically a pathway known as Th2, becomes overactivated, releasing inflammatory signals that drive the characteristic itch and inflammation of eczema.
IL-4 and IL-13 are two of the key messenger proteins in this process. They bind to receptors on immune and skin cells, triggering a cascade of inflammation. Dupixent contains antibody proteins engineered to attach to these receptors and prevent IL-4 and IL-13 from binding to them.
By blocking these two signals simultaneously, Dupixent acts on selected immune signalling pathways involved in the inflammatory process. It is designed to act more selectively on certain immune pathways than some broader systemic treatments. This is what distinguishes it from treatments like oral corticosteroids or older immunosuppressant medications.
When Dupixent Is Generally Considered
Dupixent is generally considered for individuals with moderate-to-severe atopic dermatitis whose condition has not been adequately controlled by topical treatments such as corticosteroid creams or calcineurin inhibitors.
In practice, a dermatologist will typically assess several criteria before considering Dupixent as part of a management plan. These may include:
Disease severity: the extent and intensity of skin involvement, often assessed using clinical scoring tools such as the EASI (Eczema Area and Severity Index) or IGA (Investigator's Global Assessment).
Symptom burden: the degree to which itch, sleep disruption, and skin discomfort are affecting daily life and quality of life.
Treatment history: whether adequate trials of topical treatments have been completed without achieving satisfactory control.
Overall health: a general assessment to confirm the treatment is appropriate given any other health conditions or medications.
Dupixent is not a first-line treatment; it sits within a stepwise framework where other approaches are typically considered before moving to a biologic.
How Dupixent Differs From Other Eczema Treatments
One of the most common questions about Dupixent is how it is different from treatments like steroid creams or oral immunosuppressants. The distinction lies in specificity.
Topical corticosteroids reduce inflammation locally in the skin by broadly dampening immune activity in the area where they are applied. Oral immunosuppressants such as cyclosporine work by suppressing immune activity throughout the body. These approaches are effective but carry the risk of broader effects on immune function.
Dupixent does not work as a steroid and does not suppress the immune system in a general sense. It targets a specific arm of the immune response, the IL-4 and IL-13 pathway, leaving the rest of the immune system largely unaffected.This targeted mechanism is one reason Dupixent may be discussed in selected cases of moderate-to-severe atopic dermatitis.
What Patients Generally Experience When Starting Dupixent
Dupixent is given as a subcutaneous (under-the-skin) injection. The typical schedule involves an initial higher loading dose, followed by maintenance injections every two weeks. In some cases, a four-weekly schedule may be appropriate; this is something a dermatologist would discuss.
One of the more commonly reported early side effects is conjunctivitis inflammation of the eyes. This affects a proportion of people starting Dupixent, particularly in the early months, and is something that should be discussed with the treating doctor, especially if eye symptoms occur.
The timeline of response varies between individuals. Regular clinical follow-up is part of the process, used to monitor how the skin is responding and manage any early reactions.
What to Discuss With Your Specialist
If Dupixent has come up in a conversation about your eczema, or if you are wondering whether it might be relevant to your situation, a specialist consultation is the right setting to explore this fully. Some useful questions to consider bringing to that appointment:
Would my condition be considered moderate to severe? Understanding how your eczema is classified can help frame the discussion around appropriate treatment options.
Have I exhausted what topical treatments can offer? Clarifying whether further topical options exist or whether they have already been tried helps establish where you are in the treatment pathway.
What would the assessment process involve? Asking what checks or evaluations would be done before any biologic treatment is considered can help you prepare.
What should I realistically expect in the first few months? Understanding the typical timeline of improvement and what early reactions to watch for can reduce uncertainty.
Going into a consultation with these questions prepared can make the conversation more productive and help you leave with a clearer sense of your options.
A Reassuring Perspective
Hearing about a treatment like Dupixent for the first time can feel like a significant step particularly if you have spent years managing eczema with creams and are now considering something more involved. It is natural to have questions, and to want to understand what this would mean for your day-to-day life before anything is decided.
What is worth knowing is that biologic treatments, including Dupixent, represent a relatively recent addition to the options assessed for moderate-to-severe eczema. Whether this type of treatment is appropriate is determined on an individual basis through structured clinical assessment.
Understanding your options is the first step. A consultation gives you the space to ask questions, get a proper assessment, and understand what, if anything, may be appropriate for your situation.
Take the Next Step
If you are experiencing eczema that has not been adequately controlled with topical treatments in Singapore, it may be helpful to seek a professional assessment rather than continuing to monitor the condition on your own.
At Medical & Surgical Dermatology Clinic, Dr Sue-Ann Ho Ju Ee takes a personalised approach to each consultation, focusing on understanding your concerns and discussing possible care options based on your symptoms, treatment history, and clinical assessment.
Located at Novena Medical Center, the clinic supports individuals across Singapore with comprehensive dermatology care for a wide range of chronic skin conditions, including atopic dermatitis and eczema.
Arranging a consultation may help you discuss your eczema concerns, previous treatments, and whether further treatment discussion is appropriate.
This article is for general informational purposes only. It does not constitute medical advice and is not a substitute for professional consultation with a qualified healthcare provider.
